Loading...
Loading...
India's montelukast imports from MALAYSIA total $300 across 2 shipments from 1 foreign suppliers. PHARMANIAGA RESEARCH CENTRE SDN BHD leads with $300 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include LAMBDA THERAPEUTIC RESEARCH LIMITED. This corridor reflects India's pharmaceutical import demand for montelukast — a concentrated sourcing relationship with select suppliers from MALAYSIA.

PHARMANIAGA RESEARCH CENTRE SDN BHD is the leading Montelukast supplier from MALAYSIA to India, with import value of $300 across 2 shipments. The top 5 suppliers — PHARMANIAGA RESEARCH CENTRE SDN BHD — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | PHARMANIAGA RESEARCH CENTRE SDN BHD | $300 | 2 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | LAMBDA THERAPEUTIC RESEARCH LIMITED | $300 | 2 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Montelukast suppliers from MALAYSIA to India include PHARMANIAGA RESEARCH CENTRE SDN BHD. The leading supplier is PHARMANIAGA RESEARCH CENTRE SDN BHD with import value of $300 USD across 2 shipments. India imported Montelukast worth $300 USD from MALAYSIA in total across 2 shipments.
India imported Montelukast worth $300 USD from MALAYSIA across 2 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Montelukast sourced from MALAYSIA include LAMBDA THERAPEUTIC RESEARCH LIMITED. The largest buyer is LAMBDA THERAPEUTIC RESEARCH LIMITED with $300 in imports across 2 shipments.
The total value of Montelukast imports from MALAYSIA to India is $300 USD, across 2 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists